Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.
J Clin Oncol. 2024 Jan 1;42(1):19-25.
Více informací ZDE
Risk Modeling for Individualization of the FLAME Focal Boost Approach in External Beam Radiation Therapy for Patients With Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):66-73.
Více informací ZDE
Salivary Electrostimulation in the Treatment of Radiation Therapy-Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial.
Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):142-153.
Více informací ZDE
Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial.
Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):52-62.
Více informací ZDE
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.
N Engl J Med. 2024 Feb 29;390(9):819-829.
Více informací ZDE
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.
J Clin Oncol. 2024 Feb 10;42(5):500-506.
Více informací ZDE
Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):368-377.
Více informací ZDE
Trimodality Therapy With Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907).
Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):390-401.
Více informací ZDE
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol. 2024 Mar 1;10(3):325-334.
Více informací ZDE
Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery.
Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):1049-1059.
Více informací ZDE
Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Long-Term Results From the PKUFH Randomized Phase 3 Trial.
Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):697-705.
Více informací ZDE
Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial.
Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1541-1551.
Více informací ZDE
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Lancet. 2024 Apr 6;403(10434):1341-1350.
Více informací ZDE
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med. 2024 Apr 11;390(14):1265-1276.
Více informací ZDE
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.
N Engl J Med. 2024 Apr 4;390(13):1163-1175.
Více informací ZDE
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
N Engl J Med. 2024 Apr 18;390(15):1359-1371.
Více informací ZDE
Streptococcus salivarius K12 Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors: A Randomized Controlled Trial.
J Clin Oncol. 2024 Apr 20;42(12):1426-1435.
Více informací ZDE
Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
JAMA Oncol. 2024 Apr 1;10(4):456-463.
Více informací ZDE
Hyperbaric Oxygen Therapy and Late Local Toxic Effects in Patients With Irradiated Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol. 2024 Apr 1;10(4):464-474.
Více informací ZDE
Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial.
Radiother Oncol. 2024 Apr;193:110116.
Více informací ZDE
Short course radiotherapy versus radiochemotherapy for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment.
Radiother Oncol. 2024 Apr;193:110144.
Více informací ZDE
Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - A DAHANCA 19 study.
Radiother Oncol. 2024 Apr;193:110149.
Více informací ZDE
Moderate hypofractionated radiotherapy for prostate cancer: 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial.
Radiother Oncol. 2024 Apr;193:110089.
Více informací ZDE
Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer.
Eur Urol. 2024 Apr;85(4):382-391.
Více informací ZDE
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.
Eur Urol. 2024 Apr;85(4):373-381.
Více informací ZDE
Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial.
JAMA Oncol. 2024 May 1;10(5):584-591.
Více informací ZDE
Late Toxicity of Prostate Ultrahypofractionated Radiation Therapy Compared With Moderate Hypofractionation in a Randomized Trial.
Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):110-118.
Více informací ZDE
Timing of High-Dose-Rate Brachytherapy With External Beam Radiation Therapy in Patients With Intermediate- and High-Risk Localized Prostate Cancer and Its Effects on Toxicity and Quality of Life: A Randomized Controlled Trial (THEPCA).
Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):90-99.
Více informací ZDE
Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled Trial.
Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):119-126.
Více informací ZDE
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study.
J Clin Oncol. 2024 May 10;42(14):1619-1624.
Více informací ZDE
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial.
J Clin Oncol. 2024 May 20;42(15):1799-1809.
Více informací ZDE
Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial.
J Clin Oncol. 2024 May 10;42(14):1655-1664.
Více informací ZDE
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Lancet Oncol. 2024 May;25(5):572-587.
Více informací ZDE
Perioperative Nivolumab in Resectable Lung Cancer.
N Engl J Med. 2024 May 16;390(19):1756-1769.
Více informací ZDE
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial.
J Clin Oncol. 2024 May 1;42(13):1466-1471.
Více informací ZDE
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Lancet. 2024 Jun 22;403(10445):2720-2731.
Více informací ZDE
Reduced-Volume Irradiation of Uninvolved Neck in Patients With Nasopharyngeal Cancer: Updated Results From an Open-Label, Noninferiority, Multicenter, Randomized Phase III Trial.
J Clin Oncol. 2024 Jun 10;42(17):2021-2025.
Více informací ZDE
